Analyst Research
| Report Title | Price |
|---|---|
|
Provider: Reuters Investment Profile
|
$20.00
|
|
Provider: Wright Reports
|
$472.00
|
|
Provider: GlobalData
|
$125.00
|
|
Provider: GlobalData
|
$125.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
Quick-Med Technologies Inc Announces Senior Management Changes
Quick-Med Technologies Inc announced that Bernd Liesenfeld, Ph.D. has been appointed as President of the Company and as a member of its Board of Directors. The Company also announced that CEO Ladd Greeno and Vice-President of Research & Development Jerry Olderman would be stepping aside from their management roles in the Company after a short transition period to be completed in mid-August. Both Mr. Greeno and Dr. Olderman will remain active with the Company as members of its Board of Directors and as senior advisors. Mr. Greeno shall also remain as Chairman of the Board.
Latest Developments for Quick-Med Technologies Inc
Latest Key Developments in Biotechnology
- Norda ASA Plans Delisting from Oslo Stock Exchange
- Stemline Therapeutics Inc Announces Closing Of $60 Million Public Offering Of Common Stock
- Clavis Pharma ASA Appoints Interim Chairman and Acting CEO
- Oncolytics Biotech Inc Meets Primary Endpoint For First Stage Of U.S. Phase 2 Metastatic Melanoma Trial
- Share this
- Link this
- Digg this


Follow Reuters